Joel Greenblatt's position in Abbott Laboratories is currently worth $5.24 Million. That's 0.05% of their equity portfolio (471st largest holding). The first Abbott Laboratories trade was made in Q4 2010. Since then Joel Greenblatt bought shares 23 more times and sold shares on 26 occasions. The stake costed the investor $2.51 Million, netting the investor a gain of 109% so far.